Actively Recruiting
Opioid Adherence and Support Through Innovative Texting Strategies
Led by University of New Mexico · Updated on 2026-01-20
60
Participants Needed
1
Research Sites
176 weeks
Total Duration
On this page
Sponsors
U
University of New Mexico
Lead Sponsor
N
National Institute on Drug Abuse (NIDA)
Collaborating Sponsor
AI-Summary
What this Trial Is About
The goal of this clinical trial is to examine the effects of reminder and mindfulness text messages on medication adherence and managing craving, pain, and withdrawal symptoms in people taking medications for opioid use disorder through assessment questions collected twice daily during the course of treatment. The main questions it aims to answer are: 1. Do daily medication reminder text messages increase medication adherence for people taking medications for opioid use disorder? 2. To what extent do people engage with the daily mindfulness messages? 3. What impact does daily mindfulness text message quantity have on craving, pain, forgetfulness, and withdrawal symptoms? Participants will: 1. Receive daily medication reminder text messages for at least 24 weeks (i.e., 6 months) 2. Receive up to 6 mindfulness messages per day for 4 weeks (i.e., 1 month) 3. Answer daily questions twice a day during the 4 weeks of mindfulness messages 4. Answer questions about the study when enrolling, at the end of the 4 weeks of mindfulness messages, and at 4 and 16 weeks after the end of the mindfulness messages
CONDITIONS
Official Title
Opioid Adherence and Support Through Innovative Texting Strategies
Who Can Participate
Eligibility Criteria
You may qualify if you...
- 18 years of age or older
- Have a cellphone that can receive text messages
- Have internet access to complete study surveys
- Willing to comply with all study procedures and be available for the duration of the study
- Within 6 months of starting or resuming to take daily methadone or buprenorphine (or suboxone/subutex)
- Able to understand study requirements and provide informed consent
You will not qualify if you...
History of severe allergic reactions to study medication Currently pregnant or breastfeeding Recent participation in another clinical trial within the last 30 days Presence of uncontrolled medical conditions that could affect safety
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
University of New Mexico
Albuquerque, New Mexico, United States, 87131
Actively Recruiting
Research Team
F
Frank Schwebel, PhD
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
NA
Model
SINGLE_GROUP
Primary Purpose
TREATMENT
Number of Arms
1
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here